Are Selected Cytokines and Epstein-Barr Virus DNA Load Predictors of Hepatological Complications of Epstein-Barr Virus Infection in Children?

被引:0
|
作者
Moppert, Justyna [1 ,2 ]
Domagalski, Krzysztof [3 ]
Wrotek, Sylwia [3 ]
Pawlowska, Malgorzata [1 ,2 ]
机构
[1] Nicolaus Copernicus Univ Torun, Dept Infect Dis & Hepatol, Coll Med Bydgoszcz, PL-87100 Torun, Poland
[2] Voivodeship Infect Observat Hosp Bydgoszcz, Dept Paediat Infect Dis & Hepatol, PL-85030 Bydgoszcz, Poland
[3] Nicolaus Copernicus Univ Torun, Fac Biol & Vet Sci, Dept Immunol, PL-87100 Torun, Poland
关键词
EBV infection; hepatitis; cytokines; EBV DNA load; ACUTE ACALCULOUS CHOLECYSTITIS; ADHESION MOLECULE-1 ICAM-1; LIVER-DISEASE; INTERLEUKIN-6; EXPRESSION; MORTALITY; DIAGNOSIS; ASSAY;
D O I
10.3390/jcm12196158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was to evaluate tumour necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), soluble intracellular adhesion molecules 1 (s-ICAM-1) and Epstein-Barr virus (EBV) DNA load levels as predictors of hepatological complications of EBV infection in children. The study group consisted of 54 children aged one to eighteen years, who were hospitalised from 1 December 2018 to 31 December 2020 in the Department of Paediatrics, Infectious Diseases and Hepatology and who had hepatological complications in the course of serologically and molecularly confirmed EBV infection. It was shown that IL-6, TNF-alpha, and s-ICAM-1 concentrations were the highest in patients with hepatitis and biliary pole damage. Higher EBV DNA viremia positively correlated with increased C-reactive protein (CRP) and TNF-alpha levels and increased leukocyte, lymphocyte, and monocyte counts. Increases in lymphocyte counts and TNF-alpha concentrations were observed along with increases in gamma-glutamyl transpeptidase (GGTP) activity. Increased concentrations of IL-6, TNF-alpha, and s-ICAM-1 may indicate the risk of hepatitis with concomitant biliary pole damage during EBV infection.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Epstein-Barr virus vectors for the treatment of Epstein-Barr virus-associated cancers
    Paillard, F
    HUMAN GENE THERAPY, 1998, 9 (08) : 1119 - 1120
  • [42] Epstein-Barr virus mononucleosis:: Neurologic complications
    Orti, A
    Otero, MC
    Tallón, P
    Merlos, R
    Pérez-Tamarit, D
    Morant, A
    Córdoba, J
    Asensi, F
    CLINICAL PEDIATRICS, 2003, 42 (04) : 361 - 364
  • [43] Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children
    Chen, Ruyue
    Lin, Qiang
    Zhu, Yun
    Shen, Yunyan
    Xu, Qinying
    Tang, Hanyun
    Cui, Ningxun
    Jiang, Lu
    Dai, Xiaomei
    Chen, Weiqing
    Li, Xiaozhong
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [44] Clinical significance of the Epstein-Barr virus load
    Dehée, A
    ANNALES DE BIOLOGIE CLINIQUE, 2001, 59 : 28 - 33
  • [45] Severe neurological complications in association with Epstein-Barr virus infection
    Corssmit, EPM
    Leverstein-van Hall, MA
    Portegies, P
    Bakker, P
    JOURNAL OF NEUROVIROLOGY, 1997, 3 (06) : 460 - 464
  • [46] Epstein-Barr Virus—Positive Hodgkin’s Lymphoma in a Patient with Chronic Active Epstein-Barr Virus Infection
    Kenji Tamayose
    Motoki Egashira
    Koichi Sugimoto
    Jun Ando
    Shigeo Mori
    Kazuo Oshimi
    International Journal of Hematology, 2004, 80 : 199 - 200
  • [47] DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma
    Choi, Su Jin
    Shin, Yu Su
    Kang, Byung Woog
    Kim, Jong Gwang
    Won, Kyoung-Jae
    Lieberman, Paul M.
    Cho, Hyosun
    Kang, Hyojeung
    ARCHIVES OF PHARMACAL RESEARCH, 2017, 40 (08) : 894 - 905
  • [48] Evaluation of plasma Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-associated Hodgkin lymphoma
    Usha, Masuma Khatun
    Jahan, Jasmine Akhter
    Ul Islam, Sm Rashed
    Begum, Ferdousy
    Ahsan, Chowdhury Rafiqul
    Yasmin, Mahmuda
    SAGE OPEN MEDICINE, 2021, 9
  • [49] Epstein-Barr virus in tumours
    Anagnostopoulos, I
    Hummel, M
    HISTOPATHOLOGY, 1996, 29 (04) : 297 - 315
  • [50] Epstein-Barr virus reactivation
    Ternák, G
    LANCET INFECTIOUS DISEASES, 2003, 3 (05): : 271 - 271